Extending value long after the clinical trial with real-world data
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial applications, data provenance and data quality serve as unwavering cornerstones for actionable insights. Yet, an unsettling trend has emerged in the form of "...
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
Two years ago, HealthVerity launched the Maternal Outcomes Masterset (MOM) to address the...
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
The COVID-19 pandemic illustrated how vital government communications can be for effective public...
As real-world data (RWD) continues to be increasingly utilized by the pharmaceutical industry and...
Medicaid provides much-needed healthcare coverage to over 70 million people, almost half of whom...
The use of real-world data (RWD) in pharmaceutical development is becoming increasingly prevalent...
With the start of 2024, we are moving toward a world without third-party cookies to track consumer...
With recent disruptions in the availability of real-world data (RWD) for clinical research,...
While the CDC is considered the nation’s leading authority on infectious diseases, it is also...
Traditional data aggregators are not enough The pharmaceutical industry is hitting a wall. Data aggregators, once considered reliable partners, are now liabilities facing significant challenges, including cyber threats, data restrictions, and opaque ...